Cited by 83Abdominal vascular conditions and treatmentsPeripheral Artery Disease ManagementGastrointestinal Bleeding Diagnosis and Treatment

Patient survival after open and endovascular mesenteric revascularization for chronic mesenteric ischemia

Open access
Tallarita, Tiziano, Oderich, Gustavo S., Gloviczki, Peter, Duncan, Audra A., Kalra, Manju, Cha, Stephen, Misra, Sanjay, Bower, Thomas C.·2013·Journal of Vascular Surgery

Abstract

Objective To evaluate long-term patient survival and causes of death after open (OR) or endovascular (ER) mesenteric revascularization for atherosclerotic chronic mesenteric ischemia using propensity score-matched comparison and clinical risk stratification. Methods The clinical data of 343 patients treated with mesenteric revascularization for chronic mesenteric ischemia between 1991 and 2010 were retrospectively reviewed. Clinical, anatomical, and procedure-related variables were analyzed using a multivariate model to identify independent predictors of any-cause early and late (>30 days) mortality. Cause of death was retrieved from review of the National Death Index. Patient survival was analyzed using Society for Vascular Surgery (SVS) comorbidity scores and propensity score-matched comparison based on independent predictors of any-cause mortality. Results There were 187 patients treated by OR and 156 patients treated by ER. Early procedure-related mortality was 2.6% (9/343), including five OR (2.7%) and four ER (2.6%) patients. Median follow-up was 96 ± 54 months (range, 1-168 months). There were 144 late deaths, most commonly from cardiac causes in 35% (51/144), followed by cancer in 15% (21/144), pulmonary complications in 13% (19/144), and mesenteric ischemia in 11% (16/144). A further 21 patients died from various identifiable causes, and 14 patients (10%) died of unknown causes. Overall, 25 patients (7.3%) died of mesenteric-related causes, including nine early and 16 late deaths (OR, 10/187; 8.0%, and ER, 6/156; 6.4%). Multivariate analysis identified age >80, diabetes, chronic kidney disease (CKD) stage IV or V, and home oxygen therapy as independent predictors (P < .05) of any cause of death. Diabetes and CKD stage IV or V were independently associated with mesenteric-related death (P < .05). Late patient survival at 5 years in the OR and ER groups was 75% ± 4% and 60% ± 9% for low SVS risk (<9), 52% ± 8% and 43% ± 9% for intermediate SVS risk (9-16), and 67% ± 15% and 30% ± 8% for high SVS risk (>16). Using propensity matched scores, 5-year survival was nearly identical for patients treated by OR (60%) or ER (57%; P = .7). Conclusions Long-term patient survival after mesenteric revascularization was not influenced by type of arterial reconstruction. Age >80 years, diabetes, CKD stage IV or V, and home oxygen were independent predictors of any-cause mortality. Diabetes and CKD stage IV or V were independently associated with mesenteric-related death.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2012.09.047

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tallarita, T., Oderich, G. S., Gloviczki, P., Duncan, A. A., Kalra, M., Cha, S., Misra, S., & Bower, T. C.
Affiliations
Mayo Clinic (US)
Corresponding author
Oderich, Gustavo S.
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2013-03
Volume
57
Issue
3
Pages
747-755
ISSN
0741-5214 (ISSN-L)
OpenAlex
W1971769703
Cited by
83
References
15
Citations by year
2026: 4 · 2025: 8 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 11 · 2016: 5 · 2015: 15 · 2014: 7
FWCI
8.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Vascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL098967)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
chronic mesenteric ischemia, mesenteric revascularization, open surgery, endovascular treatment, patient survival, mortality, diabetes mellitus, chronic kidney disease, home oxygen therapy, risk stratification, atherosclerosis, mortality risk factors, causes of death, pulmonary complications, cardiovascular mortality, cancer mortality
MeSH terms
Age Factors, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Ischemia, Male, Middle Aged, Oxygen Inhalation Therapy, Retrospective Studies, Risk Factors, Time Factors, Vascular Diseases, Vascular Surgical Procedures, Comorbidity, Multivariate Analysis, Chi-Square Distribution, Proportional Hazards Models, Odds Ratio, Treatment Outcome, Survivors, Risk Assessment, Renal Insufficiency, Chronic, Kaplan-Meier Estimate, Propensity Score, Endovascular Procedures, Mesenteric Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review